145 related articles for article (PubMed ID: 22977617)
1. Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Travis WD; Sarkaria IS; Jiang SX; Amano H; Sato Y; Saegusa M; Rusch VW; Satoh Y
Exp Ther Med; 2011 Nov; 2(6):1041-1045. PubMed ID: 22977617
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Biomarkers for Personalized Treatment in Pulmonary Large Cell Neuroendocrine Carcinoma: A Comparative Analysis With Adenocarcinoma.
Makino T; Mikami T; Hata Y; Otsuka H; Koezuka S; Isobe K; Tochigi N; Shibuya K; Homma S; Iyoda A
Ann Thorac Surg; 2016 Nov; 102(5):1694-1701. PubMed ID: 27368130
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
[TBL] [Abstract][Full Text] [Related]
5. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung.
Araki K; Ishii G; Yokose T; Nagai K; Funai K; Kodama K; Nishiwaki Y; Ochiai A
Lung Cancer; 2003 May; 40(2):173-80. PubMed ID: 12711118
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung.
Casali C; Stefani A; Rossi G; Migaldi M; Bettelli S; Parise A; Morandi U
Ann Thorac Surg; 2004 Jan; 77(1):247-52; discussion 252-3. PubMed ID: 14726070
[TBL] [Abstract][Full Text] [Related]
7. Correlation of genes associated with drug response to prognosis of large cell lung carcinoma.
Chen C; Jiang XL; Zhang CC; Li K
Chin J Cancer; 2011 Jul; 30(7):497-504. PubMed ID: 21718596
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
LaPoint RJ; Bourne PA; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC;
Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.
Miyoshi T; Umemura S; Matsumura Y; Mimaki S; Tada S; Makinoshima H; Ishii G; Udagawa H; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Aokage K; Hishida T; Yoshida J; Nagai K; Goto K; Tsuboi M; Tsuchihara K
Clin Cancer Res; 2017 Feb; 23(3):757-765. PubMed ID: 27507618
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung? A Case Report.
Aroldi F; Bertocchi P; Meriggi F; Abeni C; Ogliosi C; Rota L; Zambelli C; Bnà C; Zaniboni A
Case Rep Oncol; 2014 May; 7(2):478-83. PubMed ID: 25202262
[TBL] [Abstract][Full Text] [Related]
12. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.
Ferrara MG; Stefani A; Simbolo M; Pilotto S; Martini M; Lococo F; Vita E; Chiappetta M; Cancellieri A; D'Argento E; Trisolini R; Rindi G; Scarpa A; Margaritora S; Milella M; Tortora G; Bria E
Front Oncol; 2021; 11():650293. PubMed ID: 33937057
[TBL] [Abstract][Full Text] [Related]
13. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
14. Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.
Thompson ED; Stelow EB; Mills SE; Westra WH; Bishop JA
Am J Surg Pathol; 2016 Apr; 40(4):471-8. PubMed ID: 26735857
[TBL] [Abstract][Full Text] [Related]
15. Large cell neuroendocrine carcinoma of the larynx: definition of an entity.
Lewis JS; Spence DC; Chiosea S; Barnes EL; Brandwein-Gensler M; El-Mofty SK
Head Neck Pathol; 2010 Sep; 4(3):198-207. PubMed ID: 20589486
[TBL] [Abstract][Full Text] [Related]
16. A marked response to icotinib in a patient with large cell neuroendocrine carcinoma harboring an EGFR mutation: A case report.
Wang Y; Shen YH; Ma S; Zhou J
Oncol Lett; 2015 Sep; 10(3):1575-1578. PubMed ID: 26622712
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
[TBL] [Abstract][Full Text] [Related]
18. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
[TBL] [Abstract][Full Text] [Related]
20. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
